Serveur d'exploration SRAS - Curation (Ncbi)

Index « Keywords » - entrée « Drug Design »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Delivery Systems (trends) < Drug Design < Drug Development  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 126.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000F34 (2005) Jindrich Cinatl [Allemagne] ; Martin Michaelis ; Gerold Hoever ; Wolfgang Preiser ; Hans Wilhelm DoerrDevelopment of antiviral therapy for severe acute respiratory syndrome.
001056 (2005) Benjamin W. Neuman [États-Unis] ; David A. Stein ; Andrew D. Kroeker ; Michael J. Churchill ; Alice M. Kim ; Peter Kuhn ; Philip Dawson ; Hong M. Moulton ; Richard K. Bestwick ; Patrick L. Iversen ; Michael J. BuchmeierInhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers.
001072 (2005) Yuxian He [États-Unis] ; Shibo JiangVaccine design for severe acute respiratory syndrome coronavirus.
001135 (2005) Haitao Yang [République populaire de Chine] ; Weiqing Xie ; Xiaoyu Xue ; Kailin Yang ; Jing Ma ; Wenxue Liang ; Qi Zhao ; Zhe Zhou ; Duanqing Pei ; John Ziebuhr ; Rolf Hilgenfeld ; Kwok Yung Yuen ; Luet Wong ; Guangxia Gao ; Saijuan Chen ; Zhu Chen ; Dawei Ma ; Mark Bartlam ; Zihe RaoDesign of wide-spectrum inhibitors targeting coronavirus main proteases.
001229 (2005) Arun K. Ghosh [États-Unis] ; Kai Xi ; Kiira Ratia ; Bernard D. Santarsiero ; Wentao Fu ; Brian H. Harcourt ; Paul A. Rota ; Susan C. Baker ; Michael E. Johnson ; Andrew D. MesecarDesign and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors.
001256 (2005) Caterina Fattorusso [Italie] ; Sandra Gemma ; Stefania Butini ; Paul Huleatt ; Bruno Catalanotti ; Marco Persico ; Meri De Angelis ; Isabella Fiorini ; Vito Nacci ; Anna Ramunno ; Manuela Rodriquez ; Giovanni Greco ; Ettore Novellino ; Alberto Bergamini ; Stefano Marini ; Massimo Coletta ; Giovanni Maga ; Silvio Spadari ; Giuseppe CampianiSpecific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
001294 (2006) Andrea J. Dooley [États-Unis] ; Nice Shindo ; Barbara Taggart ; Jewn-Giew Park ; Yuan-Ping PangFrom genome to drug lead: identification of a small-molecule inhibitor of the SARS virus.
001362 (2006) Han-Zhong Zhang [États-Unis] ; Hong Zhang ; William Kemnitzer ; Ben Tseng ; Jindrich Cinatl ; Martin Michaelis ; Hans Wilhelm Doerr ; Sui Xiong CaiDesign and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors.
001414 (2005) Nicholas A. Meanwell [États-Unis] ; Makonen Belema ; David J. Carini ; Stanley V. D'Andrea ; John F. Kadow ; Mark Krystal ; B Narasimhulu Naidu ; Alicia Regueiro-Ren ; Paul M. Scola ; Sing-Yuen Sit ; Michael A. Walker ; Tao Wang ; Kap-Sun YeungDevelopments in antiviral drug design, discovery and development in 2004.
001419 (2006) Roberto Di Santo [Italie] ; Roberta Costi ; Alessandra Roux ; Marino Artico ; Antonio Lavecchia ; Luciana Marinelli ; Ettore Novellino ; Lucia Palmisano ; Mauro Andreotti ; Roberta Amici ; Clementina Maria Galluzzo ; Lucia Nencioni ; Anna Teresa Palamara ; Yves Pommier ; Christophe MarchandNovel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.
001476 (2006) Christophe Biot [France] ; Wassim Daher ; Natascha Chavain ; Thierry Fandeur ; Jamal Khalife ; Daniel Dive ; Erik De ClercqDesign and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities.
001507 (2006) D-Q Wei [République populaire de Chine] ; R. Zhang ; Q-S Du ; W-N Gao ; Y. Li ; H. Gao ; S-Q Wang ; X. Zhang ; A-X Li ; S. Sirois ; K-C ChouAnti-SARS drug screening by molecular docking.
001541 (2005) Qishi Du [République populaire de Chine] ; Shuqing Wang ; Zhiqin Jiang ; Weina Gao ; Yun Li ; Dongqing Wei ; Kuo-Chen ChouApplication of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides.
001623 (2006) I-Lin Lu [République populaire de Chine] ; Neeraj Mahindroo ; Po-Huang Liang ; Yi-Hui Peng ; Chih-Jung Kuo ; Keng-Chang Tsai ; Hsing-Pang Hsieh ; Yu-Sheng Chao ; Su-Ying WuStructure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease.
001654 (2006) Marcin Hoffmann [Pologne] ; Krystian Eitner ; Marcin Von Grotthuss ; Leszek Rychlewski ; Ewa Banachowicz ; Tomasz Grabarkiewicz ; Tomasz Szkoda ; Andrzej KolinskiThree dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors.
001725 (2006) Fernando Almazán [Espagne] ; Marta L. Dediego ; Carmen Galán ; Enrique Alvarez ; Luis EnjuanesIdentification of essential genes as a strategy to select a SARS candidate vaccine using a SARS-CoV infectious cDNA.
001737 (2006) Lili Chen [République populaire de Chine] ; Jian Li ; Cheng Luo ; Hong Liu ; Weijun Xu ; Gang Chen ; Oi Wah Liew ; Weiliang Zhu ; Chum Mok Puah ; Xu Shen ; Hualiang JiangBinding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features.
001802 (2006) Shuai Chen [République populaire de Chine] ; Haibin Luo ; Lili Chen ; Jing Chen ; Jianhua Shen ; Weiliang Zhu ; Kaixian Chen ; Xu Shen ; Hualiang JiangAn overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development.
001803 (2006) Luhua Lai [République populaire de Chine] ; Xiaofeng Han ; Hao Chen ; Ping Wei ; Changkang Huang ; Shiyong Liu ; Keqiang Fan ; Lu Zhou ; Zhenming Liu ; Jianfeng Pei ; Ying LiuQuaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.
001805 (2006) Haitao Yang [République populaire de Chine] ; Mark Bartlam ; Zihe RaoDrug design targeting the main protease, the Achilles' heel of coronaviruses.
001859 (2007) Qi-Shi Du [République populaire de Chine] ; Hao Sun ; Kuo-Chen ChouInhibitor design for SARS coronavirus main protease based on "distorted key theory".

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Drug Design" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Drug Design" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Drug Design
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021